Anxiety
Conditions
Interventions
This is a randomized, controlled, double-blind clinical trial with three arms. Group Transcranial Photobiomodulation: 15 women with a BAI (Beck Anxiety Inventory) score greater than 11 points will rec
Sponsors
CCS - Programa de Pós-Gradruação em Ciências da Reabilitação
CCS - Programa de Pós-Gradruação em Ciências da Reabilitação
Eligibility
Age
18 Years to 30 Years
Inclusion criteria
Inclusion criteria: Age 18 to 30 years; both sexes; a score above 11 points on the Beck Anxiety Inventory
Exclusion criteria
Exclusion criteria: Participants who do not attend on the previously determined days; those who use medication for the treatment of sleep or anxiety; those with migraines; neoplasms; neurological diseases or rheumatological diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that anxiety will decrease more significantly in the groups receiving transcranial photobiomodulation and transcranial manual therapy intervention than in the control group ;It is expected that the groups receiving transcranial photobiomodulation and transcranial manual therapy will show greater improvements in sleep quality than the control group;Improvements in postural control are expected in groups receiving transcranial photobiomodulation and transcranial manual therapy intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected | — |
Countries
Brazil
Contacts
Public ContactChristiane Macedo
Universidade Estadual de Londrina
Outcome results
None listed